International Journal of Molecular Sciences Article Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil Jung Ho Han 1,2 , MinJeong Kim 3, Hyeon Jin Kim 4 , Se Bok Jang 4, Sung-Jin Bae 2 , In-Kyu Lee 5, Dongryeol Ryu 3,* and Ki-Tae Ha 1,2,* 1 Department of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan 50612, Korea;
[email protected] 2 Healthy Aging Korean Medical Research Center, Pusan National University, Yangsan 50612, Korea;
[email protected] 3 Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon 16419, Korea;
[email protected] 4 Department of Molecular Biology, College of Natural Science, Busan 46241, Korea;
[email protected] (H.J.K.);
[email protected] (S.B.J.) 5 Department of Internal Medicine, School of Medicine Kyungpook National University, Daegu 41566, Korea;
[email protected] * Correspondence:
[email protected] (D.R.);
[email protected] (K.-T.H.) Abstract: Resistance to anticancer therapeutics occurs in virtually every type of cancer and becomes a major difficulty in cancer treatment. Although 5-fluorouracil (5FU) is the first-line choice of an- ticancer therapy for gastric cancer, its effectiveness is limited owing to drug resistance. Recently, altered cancer metabolism, including the Warburg effect, a preference for glycolysis rather than oxidative phosphorylation for energy production, has been accepted as a pivotal mechanism reg- ulating resistance to chemotherapy. Thus, we investigated the detailed mechanism and possible Citation: Han, J.H.; Kim, M.; Kim, H.J.; Jang, S.B.; Bae, S.-J.; Lee, I.-K.; usefulness of antiglycolytic agents in ameliorating 5FU resistance using established gastric cancer Ryu, D.; Ha, K.-T.